Medtronic

Company Snapshot

Founded: 1949
Entity Type: Public
Employees: 95,000
Region: U.S.
Revenue: $33,537.0 Millions
Revenue Year: 2024
Segment: Cardiovascular, Medical Surgical, Neuroscience, Diabetes
Headquarter: Dublin, Ireland
Key Geographics: U.S., Ireland
Corporate Address: Building 2 Parkmore Business Park West Co. Galway, H91 4K49, Ireland Tel: +353-1-438-1700 Website: www.medtronic.com

Company Overview

Medtronic is a medical technology, services, and solutions company. It operates in four core business segments: cardiovascular, neuroscience, medical surgery, and diabetes, offering products to hospitals, physicians, clinicians, and patients in various therapeutic areas, with operations in over 150 countries.

In the healthcare cognitive computing and AI systems market, Medtronic offers GI-Genius. This AI-assisted endoscopy platform uses advanced computer vision to analyze live endoscopic video and highlight potential abnormalities in real time. By augmenting clinician visualization and prioritizing suspicious findings during procedures, GI-Genius supports more accurate diagnosis and enhances procedural efficiency in gastrointestinal care.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Medtronic In Reports

Global Cognitive Computing and Artificial Intelligence Systems Market in Healthcare

According to BCC Research detailed report on Cognitive Computing and Artificial Intelligence Systems Market in Healthcare revenue ($ Million) for base year data of 2024, estimated year data of 2025, and forecasts...

Global Veterinary Medical Devices Market

Explore the veterinary medical device market, covering diagnostic imaging, monitoring devices, surgical tools, and growing animal healthcare demand.

Cardiovascular Devices: Global Markets to 2030

BCC Research detailed report on cardiovascular devices market data using 2024 as the base year 2025 as the estimated year, and provides CAGR projections for the 2025–2030 forecast period.

Company's Business Segments

  • Cardiovascular : Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, and Coronary & Peripheral Vascular
  • Medical Surgical : Surgical and Respiratory, Acute Care & Monitoring.
  • Neuroscience : Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation
  • Diabetes : Develops, Manufactures, Markets products and services for the management of Type 1 and Type 2 Diabetes.
  • Other Operating Segment : Includes historical operations and ongoing transition agreements from businesses the Company has exited or divested, which primarily includes the Company's Ventilator Product Line and the Renal Care Solutions Business.

Applications/End User Industries

  • Hospitals
  • Healthcare Providers
  • Surgical Centers
  • Surgeons
  • Clinics
  • Neurosurgeons
  • Endocrinologists
  • Diabetes Educators
  • Government Healthcare Agencies
  • Orthopedic Surgeons
  • Rehabilitation Professionals
  • Pain Management Specialists
  • Healthcare
AI Sentiment